Clinical Trial Update: a Neo-adjuvant Chemotherapy Immunotherapy in Resectable ESCC Study

View source ↗

Summary

Clinical trial update about a neoadjuvant chemotherapy-immunotherapy study for resectable esophageal squamous cell carcinoma. The trial is currently ACTIVE_NOT_…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Zhejiang University | Conditions: The Neoadjuvant Treatment for Resectable Esophageal Squamous Cell Carcinoma | Status: ACTIVE_NOT_RECRUITING